Clinical Trials Logo

Clinical Trial Summary

A prospective, open, randomized, pilot clinical trial which aims the assessment of quality of life (QOL) in epilepsy outpatients equipped with a wrist-worn biosensor that provides measures of electrodermal activity and accelerometry. These measures are used to automatically detect epileptic seizures that are transmitted to a mobile phone-based system for alerts and recording.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03831802
Study type Interventional
Source Centre Hospitalier Universitaire Vaudois
Contact
Status Terminated
Phase N/A
Start date October 10, 2018
Completion date August 20, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Withdrawn NCT04282681 - XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
Completed NCT01439438 - Topiramate Bioequivalence Study Brazil - Fast Phase 1
Completed NCT00150787 - Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy. Phase 3
Completed NCT00231556 - A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy Phase 3
Completed NCT03446664 - Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study N/A
Completed NCT00104416 - Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures Phase 3
Completed NCT00043901 - Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug Phase 4
Completed NCT00150813 - Monotherapy With Levetiracetam in Patients Suffering From Epilepsy. Phase 3